Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 27: - When the music does not stop
Published online by Cambridge University Press: 03 April 2024
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
Which of the following hypnotic medications has the shortest half-life?
Keywords
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 453 - 468Publisher: Cambridge University PressPrint publication year: 2024
References
Abad, VC, Guilleminault, C. Insomnia in elderly patients: recommendations for pharmacological management. Drugs Aging 2018; 35:791–817CrossRefGoogle ScholarPubMed
Alvarez Perez, P, Garcia-Antelo, MJ, Rubio-Nazabal, E. “Doctor, I hear music”: a brief review about musical hallucinations. Open Neurol J 2017; 11:11–14CrossRefGoogle ScholarPubMed
Bigelow, RT, Reed, NS, Brewster, KK, et al. Association of hearing loss with psychological distress and utilization of mental health services among adults in the United States. JAMA Network Open 2020; 3:e2010986CrossRefGoogle ScholarPubMed
Choong, C, Hunter, MD, Woodruff, PW. Auditory hallucinations in those populations that do not suffer from schizophrenia. Curr Psychiatry Rep 2007; 9:206–12CrossRefGoogle Scholar
Ciorba, A, Bianchini, C, Pelucchi, S, et al. The impact of hearing loss on the quality of life of elderly adults. Clin Interv Aging 2012; 7:159–63Google ScholarPubMed
Cosh, S, von Hanno, T, Helmer, C, et al. The association amongst visual, hearing, and dual sensory loss with depression and anxiety over 6 years: the Tromsø study. Int J Geriatr Psychiatry 2018; 33:598–605CrossRefGoogle ScholarPubMed
Evers, S, Ellger, T. The clinical spectrum of musical hallucinations. J Neurol Sci 2004; 227:55–65CrossRefGoogle ScholarPubMed
Golub, JS, Brickman, AM, Ciarleglio, AJ, et al. Association of subclinical hearing loss with cognitive performance. JAMA Otolaryngol Head Neck Surg 2020; 146:57–67CrossRefGoogle ScholarPubMed
Jan, T, Del Castillo, J. Visual hallucinations: Charles Bonnet syndrome. West J Emerg Med 2012; 13:544–7CrossRefGoogle ScholarPubMed
Kumar, S, Sedley, W, Barnes, GR, et al. A brain basis for musical hallucinations. Cortex 2014; 52:86–97CrossRefGoogle ScholarPubMed
Lin, FR, Ferrucci, L, An, Y, et al. Association of hearing impairment with brain volume changes in older adults. Neuroimage 2014; 90:84–92CrossRefGoogle ScholarPubMed
Lin, FR, Metter, EJ, O’Brien, RJ, et al. Hearing loss and incident dementia. Arch Neurol 2011; 68:214–20CrossRefGoogle ScholarPubMed
Mahmoudi, E, Basu, T, Langa, K, et al. Can hearing aids delay time to diagnosis of dementia, depression, or falls in older adults? J Am Geriatr Soc 2019; 67:2362–9CrossRefGoogle ScholarPubMed
Newsted, D, Rosen, E, Cooke, B, et al. Approach to hearing loss. Can Fam Physician 2020; 66:803–9Google ScholarPubMed
Prommer, E. Musical hallucinations and opioids: a word of caution. J Pain Symptom Manage 2005; 30:305–7CrossRefGoogle Scholar
Singh, A, Karasin, J, Madhusoodanan, S. The sound of music: a rare case of auditory Charles Bonnet syndrome in an elderly male. Ann Clin Psychiatry 2019; 31:107–10Google Scholar
Stahl, SM. Disorders of Sleep and Wakefulness and Their Treatment: Neurotransmitter Networks for Histamine and Orexin, 5. Cambridge: Cambridge University Press, 2021.Google Scholar
Stahl, SM. Does treating hearing loss prevent or slow the progress of dementia? Hearing is not all in the ears, but who’s listening? CNS Spectr 2017; 22:247–50CrossRefGoogle Scholar
Trott, M, Smith, L, Xiao, T, et al. Hearing impairment and diverse health outcomes: an umbrella review of meta-analyses of observational studies. Wien Klin Wochenschr 2021; 133:1028–41CrossRefGoogle ScholarPubMed
Völter, C, Götze, L, Dazert, S, et al. Impact of hearing loss on geriatric assessment. Clin Interv Aging 2020; 15:2453–67CrossRefGoogle ScholarPubMed
Waters, F, Blom, JD, Jardri, R, et al. Auditory hallucinations, not necessarily a hallmark of psychotic disorder. Psychol Med 2018; 48:529–36Google Scholar